Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The biochemical basis for the regulation of fibre-type determination in skeletal muscle is not well understood. In addition to the expression of particular myofibrillar proteins, type I (slow-twitch) fibres are much higher in mitochondrial content and are more dependent on oxidative metabolism than type II (fast-twitch) fibres. We have previously identified a transcriptional co-activator, peroxisome-proliferator-activated receptor-gamma co-activator-1 (PGC-1 alpha), which is expressed in several tissues including brown fat and skeletal muscle, and that activates mitochondrial biogenesis and oxidative metabolism. We show here that PGC-1 alpha is expressed preferentially in muscle enriched in type I fibres. When PGC-1 alpha is expressed at physiological levels in transgenic mice driven by a muscle creatine kinase (MCK) promoter, a fibre type conversion is observed: muscles normally rich in type II fibres are redder and activate genes of mitochondrial oxidative metabolism. Notably, putative type II muscles from PGC-1 alpha transgenic mice also express proteins characteristic of type I fibres, such as troponin I (slow) and myoglobin, and show a much greater resistance to electrically stimulated fatigue. Using fibre-type-specific promoters, we show in cultured muscle cells that PGC-1 alpha activates transcription in cooperation with Mef2 proteins and serves as a target for calcineurin signalling, which has been implicated in slow fibre gene expression. These data indicate that PGC-1 alpha is a principal factor regulating muscle fibre type determination.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These effects are distinct from what has been reported in other tissues when TFAM is overexpressed (11,12) or PGC-1α is overexpressed in muscle (38).”
From TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle (2019) · cites this paper as [38]
In the citing paper
“A single bout of endurance exercise induces a rapid and sustained increase in PGC-1α gene and protein in skeletal muscle (Mathai et al., 2008), whereas muscle-specific overexpression of PGC-1α results in a large increase in functional mitochondria (Lin et al., 2002).”
From Concurrent exercise training: do opposites distract? (2017) · cites this paper as Lin et al., 2002
In the citing paper
“PGC1-α is involved in fiber type switching, shifting fiber type distribution toward Type I oxidative fibers [39].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [39]
In the citing paper
“Forced overexpression of PGC-1α in myotubes can produce the same change 116.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [116]
In the citing paper
“Thus, high-level expression of PGC-1 may actually cause accumulation of lipids and/or incomplete oxidation products, leading to reduced insulin sensitivity, as observed in PGC-1␣ transgenic mice (267-269).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [268]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 1×
“We have previously identified a transcriptional co-activator, peroxisome-proliferator-activated receptor-γ co-activator-1 (PGC-1α), which is expressed in several tissues including brown fat and skeletal muscle, and that activates mitochondrial biogenesis and oxidative metabolis”
BackgroundSelf-citationA Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864 · cited 1×
“We have previously identified a transcriptional co-activator, peroxisome-proliferator-activated receptor-γ co-activator-1 (PGC-1α), which is expressed in several tissues including brown fat and skeletal muscle, and that activates mitochondrial biogenesis and oxidative metabolis”
BackgroundSelf-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Self-citationPeroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285 · cited 1×
“PGC-1α is expressed in skeletal muscle, and powerfully induces mitochondrial biogenesis when expressed ectopically in skeletal and cardiac myocyte”
BackgroundVega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195 · cited 1×
“We have previously identified a transcriptional co-activator, peroxisome-proliferator-activated receptor-γ co-activator-1 (PGC-1α), which is expressed in several tissues including brown fat and skeletal muscle, and that activates mitochondrial biogenesis and oxidative metabolis”
BackgroundTRANSCRIPTIONAL CONTROL OF MUSCLE DEVELOPMENT BY MYOCYTE ENHANCER FACTOR-2 (MEF2) PROTEINS
Black, B. L., & Olson, E. N. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.167 · Cited by 1,039
Self-citationA calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type
Chin, E. R., Olson, E. N., Richardson, J. A., Yang, Q., Humphries, C., Shelton, J. M., Wu, H., Zhu, W., Bassel-Duby, R., & Williams, R. S. (1998) · Genes & Development · doi:10.1101/gad.12.16.2499 · Cited by 1,011
Self-citationCalcium Ion in Skeletal Muscle: Its Crucial Role for Muscle Function, Plasticity, and Disease
Berchtold, M. W., Brinkmeier, H., & Müntener, M. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1215 · Cited by 999
Enzyme activity and fiber composition in skeletal muscle of untrained and trained men.
Gollnick, P. D., Armstrong, R. B., Saubert, C. W., Piehl, K., & Saltin, B. (1972) · Journal of Applied Physiology · doi:10.1152/jappl.1972.33.3.312 · Cited by 940 · cited 1×
“Adult skeletal muscle displays plasticity that allows conversion of different fibre types in response to chronic change in contractile demand”
BackgroundMolecular and cellular adaptation of muscle in response to exercise: perspectives of various models
Booth, F. W., & Thomason, D. B. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.2.541 · Cited by 714
Cited by
Items 301–400 of 1,031
Exercise and PGC-1α-Independent Synchronization of Type I Muscle Metabolism and Vasculature by ERRγ
Narkar, V. A., Fan, W., Downes, M., Yu, R. T., Jonker, J. W., Alaynick, W. A., Banayo, E., Karunasiri, M. S., Lorca, S., & Evans, R. M. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.019 · Cited by 183
Antioxidant signaling in skeletal muscle: A brief review
Ji, L. L. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.03.002 · Cited by 184
Miura, S., Kawanaka, K., Kai, Y., Tamura, M., Goto, M., Shiuchi, T., Minokoshi, Y., & Ezaki, O. (2007) · Endocrinology · doi:10.1210/en.2006-1646 · Cited by 183
Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation
Lelliott, C., & Vidal-Puig, A. J. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802854 · Cited by 183
Crossland, H., Constantin‐Teodosiu, D., Gardiner, S. M., Constantin, D., & Greenhaff, P. L. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.160150 · Cited by 184
“The actions of PGC-1α appear to be diverse (Handschin & Spiegelman, 2006); however, with a possible role of PGC-1α in promoting skeletal muscle glucose uptake and involvement in fibre-type switching towards more oxidative fibres (Lin et al. 2002), reduced expression in this model of endotoxaemia may have had an effect…”
ResultErkens, T., Van Poucke, M., Vandesompele, J., Goossens, K., Van Zeveren, A., & Peelman, L. J. (2006) · BMC Biotechnology · doi:10.1186/1472-6750-6-41 · Cited by 183
“The expression is higher in muscles that contain more oxidative fibres and it has been shown that PPARGC1A is an important factor in determining fibre type in that it enhances the number of oxidative muscle fibres [15,16].”
BackgroundVanderVeen, B. N., Fix, D. K., & Carson, J. A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3292087 · Cited by 184
Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance.
Vianna, C. R., Huntgeburth, M., Coppari, R., Choi, C. S., Lin, J., Krauss, S., Barbatelli, G., Tzameli, I., Kim, Y.-B., Cinti, S., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.11.003 · Cited by 181
Self-citationPGC-1α modulates denervation-induced mitophagy in skeletal muscle
Vainshtein, A., Desjardins, E. M., Armani, A., Sandri, M., & Hood, D. A. (2015) · Skeletal Muscle · doi:10.1186/s13395-015-0033-y · Cited by 181
Training for Endurance and Strength: Lessons from Cell Signaling
BAAR, K. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000233799.62153.19 · Cited by 182
Krämer, D. K., Al-Khalili, L., Guigas, B., Leng, Y., Garcia-Roves, P. M., & Krook, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702329200 · Cited by 180
Re-employment of developmental transcription factors in adult heart disease
Oka, T., Xu, J., & Molkentin, J. D. (2007) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2006.11.012 · Cited by 180
Gilde, A. J., & Van Bilsen, M. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01161.x · Cited by 178
Redox regulation of mitochondrial biogenesis
Piantadosi, C. A., & Suliman, H. B. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.014 · Cited by 177
“Other genes important for mitochondrial biogenesis include the nuclear-encoded protooncogene c-Myc, an activator of PGC-1, and the myocyte-specific enhancer factor 2A (MEF2A) [56, 57], a critical regulator of oxidative capacity in skeletal and cardiac muscle activated by NRF-1 [58–60].”
Regulation of mitochondrial biogenesis during myogenesis
Remels, A. H. V., Langen, R. C. J., Schrauwen, P., Schaart, G., Schols, A. M. W. J., & Gosker, H. R. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.029 · Cited by 177
“The regulation of oxidative profile in existing muscle fibers has been described quite extensively in the literature [Lin et al., 2002,Wang et al., 2004,Canto et al., 2007] whereas knowledge regarding the development of muscle oxidative profile and the involvement of key regulators herein during…”
BackgroundInfluentialDa Cruz, S., Parone, P. A., Lopes, V. S., Lillo, C., McAlonis-Downes, M., Lee, S. K., Vetto, A. P., Petrosyan, S., Marsala, M., Murphy, A. N., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.019 · Cited by 177
“Endurance of the muscle was expressed as a fatigue index corresponding to the time (seconds) required for the muscle contraction amplitude to fall below 50% of the starting level (Lin et al., 2002).”
InfluentialSelf-citationObesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes
Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191663.12164.77 · Cited by 176
GOFFART, S., VONKLEISTRETZOW, J., & WIESNER, R. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.06.030 · Cited by 176
Jørgensen, S. B., Treebak, J. T., Viollet, B., Schjerling, P., Vaulont, S., Wojtaszewski, J. F. P., & Richter, E. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00243.2006 · Cited by 177
Role of mitochondrial homeostasis and dynamics in Alzheimer's disease
Selfridge, J. E., E, L., Lu, J., & Swerdlow, R. H. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.057 · Cited by 175
D'Errico, I., Salvatore, L., Murzilli, S., Lo Sasso, G., Latorre, D., Martelli, N., Egorova, A. V., Polishuck, R., Madeyski-Bengtson, K., Lelliott, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016354108 · Cited by 173
Nishida, Y., Nawaz, A., Kado, T., Takikawa, A., Igarashi, Y., Onogi, Y., Wada, T., Sasaoka, T., Yamamoto, S., Sasahara, M., et al. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12530 · Cited by 174
Regulation of metabolic transcriptional co‐activators and transcription factors with acute exercise
Russell, A. P., Hesselink, M. K. C., Lo, S. K., & Schrauwen, P. (2005) · The FASEB Journal · doi:10.1096/fj.04-3168fje · Cited by 177
Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD
Gosker, H. R., Hesselink, M. K. C., Duimel, H., Ward, K. A., & Schols, A. M. W. J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00146906 · Cited by 175
Intramyocellular lipids and insulin resistance
Machann, J., Häring, H., Schick, F., & Stumvoll, M. (2004) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00339.x · Cited by 172
Gurd, B. J. (2011) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h11-070 · Cited by 171
PGC-1α buffers ROS-mediated removal of mitochondria during myogenesis
Baldelli, S., Aquilano, K., & Ciriolo, M. R. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.458 · Cited by 171
The Role of Reactive Oxygen Species in the Life Cycle of the Mitochondrion
Venditti, P., & Di Meo, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062173 · Cited by 170
“PGC-1α was first identified in brown adipose tissue [75] and was subsequently found in other mitochondria-rich tissues, such as skeletal and cardiac muscle, kidney, liver, and brain [76], in which it affects several metabolic processes [77].”
BackgroundPeroxisome Proliferator-Activated Receptor Expression Is Reduced in Skeletal Muscle in COPD
Remels, A. H., Schrauwen, P., Broekhuizen, R., Willems, J., Kersten, S., Gosker, H. R., & Schols, A. M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00144106 · Cited by 168
“It has been shown that PPAR-d and PGC-1a both have the ability to redirect fibre-type distribution in skeletal muscle to a more oxidative phenotype [11, 22 , 23].”
BackgroundThyroid Hormone as a Determinant of Metabolic and Contractile Phenotype of Skeletal Muscle
Simonides, W. S., & van Hardeveld, C. (2008) · Thyroid · doi:10.1089/thy.2007.0256 · Cited by 169
Ljubicic, V., Joseph, A.-M., Saleem, A., Uguccioni, G., Collu-Marchese, M., Lai, R. Y. J., Nguyen, L. M.-D., & Hood, D. A. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.031 · Cited by 167
Li, S., Liu, C., Li, N., Hao, T., Han, T., Hill, D. E., Vidal, M., & Lin, J. D. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.013 · Cited by 169
“This factor also regulates circadian-clock function, slow-twitch muscle-fiber formation, and heme homeostasis (Handschin et al., 2005; Lin et al., 2002; Liu et al., 2007).”
BackgroundSelf-citationPlasticity of human skeletal muscle: gene expression to in vivo function
Harridge, S. D. R. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2006.036525 · Cited by 169
“Furthermore, overexpression of peroxisome proliferators-activated receptor-γ coactivator 1α (PGC 1α, the so-called master regulator of mitochondrial biogenesis) also leads to mouse muscles being dominated by red, type I fibres, suggesting that in addition to regulating mitochondrial biogenesis it also controls other g…”
BackgroundBaxendale, S., Davison, C., Muxworthy, C., Wolff, C., Ingham, P. W., & Roy, S. (2004) · Nature Genetics · doi:10.1038/ng1280 · Cited by 168
Cannavino, J., Brocca, L., Sandri, M., Grassi, B., Bottinelli, R., & Pellegrino, M. A. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.286740 · Cited by 166
“As fast muscles rely mainly on glycolytic metabolisms, have much lower mitochondrial content (Jackman & Willis, 1996; Berchtold et al. 2000; Lin et al. 2002), and express PGC-1α at low levels (Lin et al.”
BackgroundMethodInfluentialRay Hamidie, R. D., Yamada, T., Ishizawa, R., Saito, Y., & Masuda, K. (2015) · Metabolism · doi:10.1016/j.metabol.2015.07.010 · Cited by 164
“[56] Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, et al.”
BackgroundMitochondrial dysfunction in glaucoma and emerging bioenergetic therapies
Lee, S., Van Bergen, N. J., Kong, G. Y., Chrysostomou, V., Waugh, H. S., O’Neill, E. C., Crowston, J. G., & Trounce, I. A. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2010.07.015 · Cited by 169
Sun, X., & Zemel, M. B. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-26 · Cited by 164
“PGC-1α is key nuclear receptor co-activator for mitochondrial biogenesis, and over-expression of this gene in mouse skeletal muscle increases mitochondrial abundance, especially in type II fiber rich muscles, resulting in increased energy expenditure and reduced body weight [31-33].”
Pogozelski, A. R., Geng, T., Li, P., Yin, X., Lira, V. A., Zhang, M., Chi, J.-T., & Yan, Z. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007934 · Cited by 164
Nikolić, N., Skaret Bakke, S., Tranheim Kase, E., Rudberg, I., Flo Halle, I., Rustan, A. C., Thoresen, G. H., & Aas, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033203 · Cited by 167
Ljubicic, V., Miura, P., Burt, M., Boudreault, L., Khogali, S., Lunde, J. A., Renaud, J.-M., & Jasmin, B. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr265 · Cited by 162
PPARδ as a therapeutic target in metabolic disease
Reilly, S. M., & Lee, C.-H. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.040 · Cited by 164
“This phenotype resembles that of muscle-specific over-expression of peroxisome proliferators-activated receptor γ co-activator 1α (PGC-1α), indicating a functional interaction between PPARδ and PGC-1α in muscle [20].”
BackgroundElectrical Stimulation Counteracts Muscle Decline in Seniors
Kern, H., Barberi, L., Löfler, S., Sbardella, S., Burggraf, S., Fruhmann, H., Carraro, U., Mosole, S., Sarabon, N., Vogelauer, M., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00189 · Cited by 161
“Since down-regulation of PGC1α could point to altered mitochondrial function and therefore to potential increase in ROS production, we monitored the expression of Nrf2, a transcription factor that has a central role in oxidative stress response in worms, flies, and mice.”
BackgroundMethodInfluentialEndothelial PGC-1α Mediates Vascular Dysfunction in Diabetes
Sawada, N., Jiang, A., Takizawa, F., Safdar, A., Manika, A., Tesmenitsky, Y., Kang, K.-T., Bischoff, J., Kalwa, H., Sartoretto, J. L., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.014 · Cited by 163
PGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
ER stress in skeletal muscle remodeling and myopathies
Afroze, D., & Kumar, A. (2019) · The FEBS Journal · doi:10.1111/febs.14358 · Cited by 158
Laganière, J., Tremblay, G. B., Dufour, C. R., Giroux, S., Rousseau, F., & Giguère, V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313543200 · Cited by 167
Decorin Gene Transfer Promotes Muscle Cell Differentiation and Muscle Regeneration
Li, Y., Li, J., Zhu, J., Sun, B., Branca, M., Tang, Y., Foster, W., Xiao, X., & Huard, J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300250 · Cited by 161
Joseph, A.-M., Adhihetty, P. J., Wawrzyniak, N. R., Wohlgemuth, S. E., Picca, A., Kujoth, G. C., Prolla, T. A., & Leeuwenburgh, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069327 · Cited by 161
Physiological functions of peroxisome proliferator-activated receptor β
Neels, J. G., & Grimaldi, P. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00027.2013 · Cited by 161
Johri, A., Calingasan, N. Y., Hennessey, T. M., Sharma, A., Yang, L., Wille, E., Chandra, A., & Beal, M. F. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr541 · Cited by 158
Morris, G., Berk, M., Galecki, P., Walder, K., & Maes, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9090-9 · Cited by 161
“fatigue [233].”
ResultExercise-Released Myokines in the Control of Energy Metabolism
Laurens, C., Bergouignan, A., & Moro, C. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00091 · Cited by 159
“Thus, a skeletal muscle-specific overexpression of PGC-1α and PPARβ markedly improves oxidative capacity and endurance in mice (Lin et al., 2002; Wang et al., 2004).”
BackgroundExercise training in chronic heart failure: improving skeletal muscle O2transport and utilization
Hirai, D. M., Musch, T. I., & Poole, D. C. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00469.2015 · Cited by 158
Li, L., Pan, R., Li, R., Niemann, B., Aurich, A.-C., Chen, Y., & Rohrbach, S. (2011) · Diabetes · doi:10.2337/db10-0331 · Cited by 158
Rapid exercise-induced changes in PGC-1α mRNA and protein in human skeletal muscle
Mathai, A. S., Bonen, A., Benton, C. R., Robinson, D. L., & Graham, T. E. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00847.2007 · Cited by 158
Ito, K., Caramori, G., & Adcock, I. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111674 · Cited by 168
Impact of Aging and Exercise on Mitochondrial Quality Control in Skeletal Muscle
Kim, Y., Triolo, M., & Hood, D. A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3165396 · Cited by 158
Eckardt, K., Taube, A., & Eckel, J. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9168-2 · Cited by 181
“PGC-1α is preferentially expressed in muscle enriched with type I fibers [72], while muscle of sedentary individuals commonly contain more type IIB fibers.”
BackgroundNuclear receptors, mitochondria and lipid metabolism
Alaynick, W. A. (2008) · Mitochondrion · doi:10.1016/j.mito.2008.02.001 · Cited by 159
Hammarstedt, A., Jansson, P.-A., Wesslau, C., Yang, X., & Smith, U. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00014-7 · Cited by 156
Pearen, M. A., Myers, S. A., Raichur, S., Ryall, J. G., Lynch, G. S., & Muscat, G. E. O. (2008) · Endocrinology · doi:10.1210/en.2007-1202 · Cited by 158
“Both PGC-1 and - control fatty acid oxidation and mitochondrial oxidative energy metabolism in type I (and IIA) slow twitch (64) and IIX (fast twitch) muscle fibers, respectively (65).”
BackgroundOxidative Stress and Transcriptional Regulation in Alzheimer Disease
Shi, Q., & Gibson, G. E. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815721c3 · Cited by 157
Acclimatization of skeletal muscle mitochondria to high‐altitude hypoxia during an ascent of Everest
Levett, D. Z., Radford, E. J., Menassa, D. A., Graber, E. F., Morash, A. J., Hoppeler, H., Clarke, K., Martin, D. S., Ferguson‐Smith, A. C., Montgomery, H. E., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-197772 · Cited by 153
Altered Skeletal Muscle Phenotypes in Calcineurin Aα and Aβ Gene-Targeted Mice
Parsons, S. A., Wilkins, B. J., Bueno, O. F., & Molkentin, J. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4331-4343.2003 · Cited by 157
Felszeghy, S., Viiri, J., Paterno, J. J., Hyttinen, J. M. T., Koskela, A., Chen, M., Leinonen, H., Tanila, H., Kivinen, N., Koistinen, A., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2018.09.011 · Cited by 155
High-fat diet, muscular lipotoxicity and insulin resistance
Schrauwen, P. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s0029665107005277 · Cited by 153
“Many of the oxidative genes are under transcriptional control of PPARg coactivator-1a (PGC-1a), which stimulates oxidative phosphorylation, mitochondrial biogenesis and the generation of oxidative type 1 muscle fibres (Lin et al. 2002).”
BackgroundDifferential response of skeletal muscles to mTORC1 signaling during atrophy and hypertrophy
Bentzinger, C. F., Lin, S., Romanino, K., Castets, P., Guridi, M., Summermatter, S., Handschin, C., Tintignac, L. A., Hall, M. N., & Rüegg, M. A. (2013) · Skeletal Muscle · doi:10.1186/2044-5040-3-6 · Cited by 153
Tipping the metabolic scales towards increased longevity in mammals
Riera, C. E., & Dillin, A. (2015) · Nature Cell Biology · doi:10.1038/ncb3107 · Cited by 153
Transcriptional coactivator PGC-1α regulates chondrogenesis via association with Sox9
Kawakami, Y., Tsuda, M., Takahashi, S., Taniguchi, N., Esteban, C. R., Zemmyo, M., Furumatsu, T., Lotz, M., Belmonte, J. C. I., & Asahara, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407510102 · Cited by 154
PGC-1α supports glutamine metabolism in breast cancer
McGuirk, S., Gravel, S.-P., Deblois, G., Papadopoli, D. J., Faubert, B., Wegner, A., Hiller, K., Avizonis, D., Akavia, U. D., Jones, R. G., et al. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-22 · Cited by 154
“Wild-type mice (C57BL/6J) and muscle creatine kinase (mck)-PGC-1α transgenic mice (C57BL/6-Tg(Ckm-Ppargc1a)31Brsp/J) as described in [14] were purchased from The Jackson Laboratory (Bar Harbor, ME, USA).”
MethodQuiat, D., Voelker, K. A., Pei, J., Grishin, N. V., Grange, R. W., Bassel-Duby, R., & Olson, E. N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107413108 · Cited by 151
Self-citationMitochondrial biogenesis and turnover
Diaz, F., & Moraes, C. T. (2008) · Cell Calcium · doi:10.1016/j.ceca.2007.12.004 · Cited by 188
You, J.-S., Anderson, G. B., Dooley, M. S., & Hornberger, T. A. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019414 · Cited by 150
“…proliferator-activated receptor γ coactivator 1α (PGC1α) than glycolytic fiber types, and that overexpression of PGC1α inhibits the expression of atrophy-related genes as well as denervation- and fasting-induced muscle atrophy (Lin et al., 2002; Russell et al., 2003; Sandri et al., 2006).”
Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models
Komen, J. C., & Thorburn, D. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12413 · Cited by 149
“British Journal of Pharmacology (2014) 171 1818–1836 1821 Rescue of mitochondrial dysfunction by transgenic PGC-1α expression The phenotype in a mouse model of DMD, mdx mice, benefitted significantly from transgenic PGC-1α expression in skeletal muscle (Lin et al., 2002; Handschin et al., 2007).”
BackgroundColl, T., Jové, M., Rodríguez-Calvo, R., Eyre, E., Palomer, X., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M. (2006) · Diabetes · doi:10.2337/db05-1494 · Cited by 151
Mitochondria and PGC-1α in Aging and Age-Associated Diseases
Wenz, T. (2011) · Journal of Aging Research · doi:10.4061/2011/810619 · Cited by 148
“The changed transcription program upon exercise induces changes in muscle plasticity such as a fiber-type switching towards more oxidative fibers and induces the mitochondrial antioxidant program [70, 73, 74].”
BackgroundWan, Z., Root‐Mccaig, J., Castellani, L., Kemp, B. E., Steinberg, G. R., & Wright, D. C. (2014) · Obesity · doi:10.1002/oby.20605 · Cited by 146
Alternative mRNA Splicing Produces a Novel Biologically Active Short Isoform of PGC-1α
Zhang, Y., Huypens, P., Adamson, A. W., Chang, J. S., Henagan, T. M., Boudreau, A., Lenard, N. R., Burk, D., Klein, J., Perwitz, N., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.037556 · Cited by 148
Calsarcin-2 deficiency increases exercise capacity in mice through calcineurin/NFAT activation
Frey, N., Frank, D., Lippl, S., Kuhn, C., Kögler, H., Barrientos, T., Rohr, C., Will, R., Müller, O. J., Weiler, H., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36277 · Cited by 150
Self-citationSox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice
Hagiwara, N., Yeh, M., & Liu, A. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21223 · Cited by 149
“Examples include Ras (Murgia et al., 2000), calcineurin (Chin et al., 1998; Naya et al., 2000; Serrano et al., 2001), PGC1- (Lin et al., 2002), PPAR (Wang et al., 2004), MusTRD/GTF3 (Calvo et al., 2001; Polly et al., 2003), and MRFs (Hughes et al., 1993, 1997; Voytik et al., 1993).”
BackgroundMiura, S., Kai, Y., Ono, M., & Ezaki, O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304312200 · Cited by 146
Meng, Z.-X., Li, S., Wang, L., Ko, H. J., Lee, Y., Jung, D. Y., Okutsu, M., Yan, Z., Kim, J. K., & Lin, J. D. (2013) · Nature Medicine · doi:10.1038/nm.3144 · Cited by 146
Self-citationYAMASHITA, H., MARUTA, H., JOZUKA, M., KIMURA, R., IWABUCHI, H., YAMATO, M., SAITO, T., FUJISAWA, K., TAKAHASHI, Y., KIMOTO, M., et al. (2009) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.80634 · Cited by 146
Noh, Y. H., Kim, K.-Y., Shim, M. S., Choi, S.-H., Choi, S., Ellisman, M. H., Weinreb, R. N., Perkins, G. A., & Ju, W.-K. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.341 · Cited by 144
Mechanisms of statin-associated skeletal muscle-associated symptoms
Bouitbir, J., Sanvee, G. M., Panajatovic, M. V., Singh, F., & Krähenbühl, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.010 · Cited by 136
Mediators of Physical Activity Protection against ROS-Linked Skeletal Muscle Damage
Di Meo, S., Napolitano, G., & Venditti, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123024 · Cited by 145
“Subsequently, it was found in other mitochondria-rich tissues, including skeletal and cardiac muscle, as well as in kidney, liver, and brain [246] in which it influences numerous aspects of metabolism [247].”
BackgroundMeng, Q., Qi, X., Fu, Y., Chen, Q., Cheng, P., Yu, X., Sun, X., Wu, J., Li, W., Zhang, Q., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112326 · Cited by 145
Double Muscling in Cattle: Genes, Husbandry, Carcasses and Meat
Fiems, L. O. (2012) · Animals · doi:10.3390/ani2030472 · Cited by 141
“PGC-1 is expressed preferentially in muscle enriched in Type I fibers [166].”
BackgroundSuppression of β Cell Energy Metabolism and Insulin Release by PGC-1α
Yoon, J. C., Xu, G., Deeney, J. T., Yang, S.-N., Rhee, J., Puigserver, P., Levens, A. R., Yang, R., Zhang, C.-Y., Lowell, B. B., et al. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00170-9 · Cited by 143
Self-citationKleiner, S., Nguyen-Tran, V., Baré, O., Huang, X., Spiegelman, B., & Wu, Z. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008797 · Cited by 143
Self-citationBenton, C. R., Holloway, G. P., Han, X.-X., Yoshida, Y., Snook, L. A., Lally, J., Glatz, J. F. C., Luiken, J. J. F. P., Chabowski, A., & Bonen, A. (2010) · Diabetologia · doi:10.1007/s00125-010-1773-1 · Cited by 154
“The correlations between PGC-1α and rodent muscle oxidative capacity, and between PGC-1α and both GLUT4 and FAT support the idea that in lean and obese muscles PGC-1α is central to a coordinated metabolic programme that upregulates a number of genes simultaneously to produce an oxidative muscle phenotype that relies e…”
BackgroundPGC-1α: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes
Soyal, S. M., Krempler, F., Oberkofler, H., & Patsch, W. (2006) · Diabetologia · doi:10.1007/s00125-006-0268-6 · Cited by 162
Exercise: Putting Action into Our Epigenome
Denham, J., Marques, F. Z., O’Brien, B. J., & Charchar, F. J. (2013) · Sports Medicine · doi:10.1007/s40279-013-0114-1 · Cited by 167
Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study
Abdellaoui, A., Préfaut, C., Gouzi, F., Couillard, A., Coisy-Quivy, M., Hugon, G., Molinari, N., Lafontaine, T., Jonquet, O., Laoudj-Chenivesse, D., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00167110 · Cited by 144
PGC-1α regulates a HIF2α-dependent switch in skeletal muscle fiber types
Rasbach, K. A., Gupta, R. K., Ruas, J. L., Wu, J., Naseri, E., Estall, J. L., & Spiegelman, B. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016089107 · Cited by 145
Self-citationMultiple Roles in Neuroprotection for the Exercise Derived Myokine Irisin
Farshbaf, M. J., & Alviña, K. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.649929 · Cited by 159
“As co-activator, PGC-1α interacts with a wide range of transcription factors and it is expressed in high energy demand tissues such as skeletal muscle, heart, and brain (Lin et al., 2002; Buroker et al., 2008; Katsouri et al., 2016).”
BackgroundStefan, N., Thamer, C., Staiger, H., Machicao, F., Machann, J., Schick, F., Venter, C., Niess, A., Laakso, M., Fritsche, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1785 · Cited by 139
“PGC1 and PPAR are major candidates that interact with each other to influence these factors (6–9).”
BackgroundInfluentialMuller, Y. L., Bogardus, C., Pedersen, O., & Baier, L. (2003) · Diabetes · doi:10.2337/diabetes.52.3.895 · Cited by 142
Exercise Training and Peripheral Arterial Disease
Haas, T. L., Lloyd, P. G., Yang, H., & Terjung, R. L. (2012) · Comprehensive physiology · doi:10.1002/cphy.c110065 · Cited by 177
Metadata
- Authors
- Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., Lowell, B. B., Bassel-Duby, R., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- Beth Israel Deaconess Medical Center (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2002-08
- Volume
- 418
- Issue
- 6899
- Pages
- 797-801
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2053765200
- Cited by
- 2,546
- References
- 27
- Citations by year
- 2026: 61 · 2025: 78 · 2024: 85 · 2023: 80 · 2022: 99 · 2021: 100 · 2020: 108 · 2019: 111 · 2018: 124 · 2017: 113 · 2016: 132 · 2015: 132 · 2014: 114 · 2013: 159 · 2012: 146
- FWCI
- 26.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Science Foundation
- Japan Society for the Promotion of Science
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- PGC-1α, slow-twitch muscle fibres, skeletal muscle, mitochondrial biogenesis, oxidative metabolism, MEF2, transgenic mice, fatigue resistance, myoglobin, troponin I
- MeSH terms
- Animals, Cell Line, Creatine Kinase, DNA-Binding Proteins, Electric Stimulation, Isoenzymes, Mice, Transgenic, Myoglobin, Promoter Regions, Genetic, Transcription Factors, Transcription, Genetic, Transcriptional Activation, Myogenic Regulatory Factors, Muscle, Skeletal, Muscle Fibers, Slow-Twitch, Muscle Fatigue, Transgenes, Troponin I, Mice, Creatine Kinase, MM Form, MEF2 Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.